ArticleFrontiers in molecular biosciences2024

Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment.

Qingxin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.